Filed: 8/14/2025ACC: 0000950142-25-002176
📋 What this filing means
GENERAL ATLANTIC, L.P. filed this quarterly 13F‑HR report disclosing 15 equity positions with a total reported market value of $3.63B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
15
Positions
$3.63B
Total AUM (reported)
219.90M
Total Shares
Allocation by class
CL A$1.40B38.5%
COM$1.35B37.2%
COM SHS CL A$662.89M18.3%
ADS$134.68M3.7%
ORD SHS$85.49M2.4%
Portfolio Concentration
Top 3$2.00B55.2%
4–10$1.53B42.2%
11–25$94.82M2.6%
Top 3 weight
55.2%
Top 10 weight
97.4%
Voting Authority Distribution
Total shares with voting rights: 219.90M
Sole
Full voting authority
219.90M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole15
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings15
Rows:
DLOCAL
SOLEShares63.91M
TypeSH
Market value$724.70M
19.97%
Sole
63.91M
Shared
0.00
None
0.00
CHIME
SOLEShares19.21M
TypeSH
Market value$662.89M
18.26%
Sole
19.21M
Shared
0.00
None
0.00
ALIGNMENT HEALTHCARE
SOLEShares43.99M
TypeSH
Market value$615.91M
16.97%
Sole
43.99M
Shared
0.00
None
0.00
XP, INC
SOLEShares25.52M
TypeSH
Market value$515.46M
14.20%
Sole
25.52M
Shared
0.00
None
0.00
AKERO THERAPEUTICS
SOLEShares5.73M
TypeSH
Market value$305.97M
8.43%
Sole
5.73M
Shared
0.00
None
0.00
ALKAMI
SOLEShares9.65M
TypeSH
Market value$290.71M
8.01%
Sole
9.65M
Shared
0.00
None
0.00
PHARVARIS
SOLEShares7.53M
TypeSH
Market value$132.55M
3.65%
Sole
7.53M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS
SOLEShares9.68M
TypeSH
Market value$127.22M
3.51%
Sole
9.68M
Shared
0.00
None
0.00
WEBULL
SOLEShares7.15M
TypeSH
Market value$85.49M
2.36%
Sole
7.15M
Shared
0.00
None
0.00
EUROPEAN WAX CENTER
SOLEShares13.11M
TypeSH
Market value$73.81M
2.03%
Sole
13.11M
Shared
0.00
None
0.00
ROYALTY PHARMA
SOLEShares1.50M
TypeSH
Market value$54.05M
1.49%
Sole
1.50M
Shared
0.00
None
0.00
RISKIFIED
SOLEShares5.32M
TypeSH
Market value$26.57M
0.73%
Sole
5.32M
Shared
0.00
None
0.00
ADAGENE
SOLEShares3.83M
TypeSH
Market value$7.46M
0.21%
Sole
3.83M
Shared
0.00
None
0.00
ALUMIS
SOLEShares1.30M
TypeSH
Market value$3.89M
0.11%
Sole
1.30M
Shared
0.00
None
0.00
GROVE COLLABORATIVE
SOLEShares2.47M
TypeSH
Market value$2.85M
0.08%
Sole
2.47M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DLOCALSOLE | CL A | 63.91M | SH | $724.70M 19.97% | 63.91M | 0.00 | 0.00 |
CHIMESOLE | COM SHS CL A | 19.21M | SH | $662.89M 18.26% | 19.21M | 0.00 | 0.00 |
ALIGNMENT HEALTHCARESOLE | COM | 43.99M | SH | $615.91M 16.97% | 43.99M | 0.00 | 0.00 |
XP, INCSOLE | CL A | 25.52M | SH | $515.46M 14.20% | 25.52M | 0.00 | 0.00 |
AKERO THERAPEUTICSSOLE | COM | 5.73M | SH | $305.97M 8.43% | 5.73M | 0.00 | 0.00 |
ALKAMISOLE | COM | 9.65M | SH | $290.71M 8.01% | 9.65M | 0.00 | 0.00 |
PHARVARISSOLE | COM | 7.53M | SH | $132.55M 3.65% | 7.53M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALSSOLE | ADS | 9.68M | SH | $127.22M 3.51% | 9.68M | 0.00 | 0.00 |
WEBULLSOLE | ORD SHS | 7.15M | SH | $85.49M 2.36% | 7.15M | 0.00 | 0.00 |
EUROPEAN WAX CENTERSOLE | CL A | 13.11M | SH | $73.81M 2.03% | 13.11M | 0.00 | 0.00 |
ROYALTY PHARMASOLE | CL A | 1.50M | SH | $54.05M 1.49% | 1.50M | 0.00 | 0.00 |
RISKIFIEDSOLE | CL A | 5.32M | SH | $26.57M 0.73% | 5.32M | 0.00 | 0.00 |
ADAGENESOLE | ADS | 3.83M | SH | $7.46M 0.21% | 3.83M | 0.00 | 0.00 |
ALUMISSOLE | COM | 1.30M | SH | $3.89M 0.11% | 1.30M | 0.00 | 0.00 |
GROVE COLLABORATIVESOLE | CL A | 2.47M | SH | $2.85M 0.08% | 2.47M | 0.00 | 0.00 |